☰

Richard J. Schwartz - Publications

Affiliations: 
1964-2009 Electrical and Computer Engineering Purdue University, West Lafayette, IN, United States 
Area:
solar cell energy
Website:
https://engineering.purdue.edu/Engr/AboutUs/News/Publications/EngineeringImpact/2009_1/ECE_Issue/AnIlluminatingCareer
Tree Info Similar researchers PubMed Report error

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Vij R, Wang M, Orlowski R, Stewart AK, Jagannath S, Kukreti V, Taylor J, Fuhrman D, Cruickshank S, Schwartz R, Kunkel L, Siegel D. Initial Results of PX-171-004, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM) Blood. 112: 865-865. DOI: 10.1182/Blood.V112.11.865.865  0.419
2008 Jagannath S, Vij R, Stewart AK, Somlo G, Jakubowiak A, Reiman T, Trudel S, Taylor J, Fuhrman D, Cruickshank S, Schwartz R, Kunkel L, Siegel D. Initial Results of PX-171-003, An Open-Label, Single-Arm, Phase II Studyof Carfilzomib (CFZ) in Patients with Relapsed and Refractory Multiple Myeloma (MM) Blood. 112: 864-864. DOI: 10.1182/Blood.V112.11.864.864  0.418
2007 Khoury HJ, Michallet M, Corm S, Roy L, Jones D, Hochhaus A, Kantarjian H, Benichou A, Schwartz R, Cortes J. Safety and Efficacy Study of Subcutaneous Homoharringtonine (SC HHT) in Imatinib (IM)-Resistant Chronic Myeloid Leukemia (CML) with the T315I Mutation - Initial Report of a Phase II Trial. Blood. 110: 1050-1050. DOI: 10.1182/Blood.V110.11.1050.1050  0.38
Show low-probability matches.